Literature DB >> 15815208

Ileostomy adenocarcinomas in the setting of ulcerative colitis.

Hardean E Achneck1, Ilene Y Wong, Paul J Kim, Myriam A Fernandes, Zenta Walther, Neal E Seymour, Dhanpat Jain.   

Abstract

Adenocarcinomas arising at ileostomy sites in patients after colon resection for various diseases, such as ulcerative colitis (UC), familial adenomatous polyposis coli, and Crohn's disease, are rare occurrences but have been reported increasingly in the last 20 years. We report a case of adenocarcinoma arising in an ileostomy site in an 85-year-old woman with longstanding UC. She had pancolitis and underwent total proctocolectomy. Thirty-nine years later, her ileostomy site developed a granulation tissue-type lesion, which on initial biopsy revealed cytologic atypia in the presence of marked inflammation. A subsequent biopsy revealed adenocarcinoma with signet-ring cells and abundant extracellular mucin. Resection of the ileostomy was undertaken and a new ileostomy was performed. The literature on adenocarcinoma arising in the 23 patients with ulcerative colitis who received a Brooke or Kock ileostomy and had no prior history of neoplasm is reviewed.

Entities:  

Mesh:

Year:  2005        PMID: 15815208     DOI: 10.1097/01.mcg.0000159216.39795.4a

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Short bowel syndrome after continence-preserving procedures.

Authors:  Jon S Thompson; Richard Gilroy; Debra Sudan
Journal:  J Gastrointest Surg       Date:  2007-10-30       Impact factor: 3.452

Review 2.  A systematic review of primary ileostomy site malignancies.

Authors:  Anthony Onde Morada; Sri Harshavardhan Senapathi; Amir Bashiri; Seungwoo Chai; Burt Cagir
Journal:  Surg Endosc       Date:  2022-01-07       Impact factor: 4.584

3.  Minimally invasive treatment of peristomal metastases from gastric cancer at an ileostomy site by electrochemotherapy.

Authors:  Luca G Campana; Marco Scarpa; Antonio Sommariva; Elena Bonandini; Sara Valpione; Leonardo Sartore; Carlo R Rossi
Journal:  Radiol Oncol       Date:  2013-10-08       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.